Altre lingue Amphastar Pharmaceuticals, Inc.

Azioni

AMPH

US03209R1032

Tempo reale stimato Cboe BZX Altri mercati azionari 18:24:08 26/04/2024			Variaz. 5gg	Var. 1 gen.
41,16 ^USD	+0,82%		+3,00%	-33,37%

13/03	Transcript : Amphastar Pharmaceuticals, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 11:15 AM
08/03	Un insider di Amphastar Pharmaceuticals ha venduto azioni per un valore di 842.883 dollari, secondo un recente documento della SEC	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Amphastar Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference	02/04
Amphastar Pharmaceuticals Insider Sold Shares Worth $842,883, According to a Recent SEC Filing	08/03
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2023	29/02
Sector Update: Health Care Stocks Advance Premarket Thursday	29/02
Amphastar Pharmaceuticals Q4 Adjusted Earnings, Revenue Rise	29/02
Amphastar Pharmaceuticals, Inc. Reports Impairment of Long-Lived Assets for the Fourth Quarter Ended December 31, 2023	28/02
Amphastar Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	28/02
Amphastar: Q4 Earnings Snapshot	28/02
Earnings Flash (AMPH) AMPHASTAR PHARMACEUTICALS Posts Q4 EPS $0.88, vs. Street Est of $0.91	28/02
Earnings Flash (AMPH) AMPHASTAR PHARMACEUTICALS Reports Q4 Revenue $178.1M, vs. Street Est of $173.3M	28/02
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 28, 2024	21/02
High-dose opioid reversal spray no better than lower dose in field, US study finds	08/02
Amphastar Pharmaceuticals Insider Sold Shares Worth $7,171,768, According to a Recent SEC Filing	11/01
Amphastar Pharmaceuticals Insider Sold Shares Worth $12,798,708, According to a Recent SEC Filing	11/01
Amphastar Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference	03/01
MannKind Restructures Supply Agreement with Amphastar Pharmaceuticals	28/12
Amphastar Pharmaceuticals Insider Sold Shares Worth $223,446, According to a Recent SEC Filing	21/11
Amphastar Pharmaceuticals Insider Sold Shares Worth $262,500, According to a Recent SEC Filing	15/11
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2023	09/11
Amphastar: Q3 Earnings Snapshot	09/11

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Amphastar Pharmaceuticals, Inc.

Azioni

AMPH

US03209R1032

Altre lingue

Filtri